Core First Bank & Trust Novartis Ag Transaction History
Core First Bank & Trust
- $154 Million
- Q1 2025
A detailed history of Core First Bank & Trust transactions in Novartis Ag stock. As of the latest transaction made, Core First Bank & Trust holds 3,010 shares of NVS stock, worth $351,056. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,010
Previous 2,310
30.3%
Holding current value
$351,056
Previous $224,000
49.55%
% of portfolio
0.22%
Previous 0.13%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,544Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.38 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.21 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$823 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$789 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...